Eric Black-Maier, MD

Start Year

Education and Training

University of Oregon

Medical School
Duke University

Duke University

Career and Research Goals

My top priorities are taking great care of patients and developing into a well rounded cardiologist. I plan on pursuing advanced training in cardiac electrophysiology.

My research interests include catheter ablation and pharmacological therapy for atrial fibrillation, and cardiovascular implantable electronic device therapy and management.

Honors, awards and distinctions

Howard Hughes Institute Medical Research Fellow (2012-3)

Fellow Perspective

Tell us briefly about your background before fellowship?
I grew up and attended college in Oregon. I moved to Durham to attend medical school in 2010 and developed an interest in cardiology during first and second year physiology coursework. I remained interested in cardiology as an internal medicine resident at Duke and my research interests shifted toward clinical electrophysiology.
What are your career plans in cardiology?
I plan to pursue advanced training in cardiac electrophysiology. 

Why did you choose Duke for your fellowship training?
Duke is a program with a unique blend of clinical strengths across all domains of cardiology and exposure to quality research training. Faculty engagement and respect for fellow autonomy is outstanding.

What advice might you offer residents looking at fellowship programs?
Applying to cardiology fellowship is much different from internal medicine residency. The quality of didactics and training is important, but mentorship becomes critical. Consider your specific goals within cardiology and both the clinical and research mentorship that will be available to you.

From your experience in fellowship, what have you learned about training at Duke?
The faculty has designed a fellowship program that is truly “high yield,” and we spend most of our time in the hospital actively developing the requisite skills and knowledge to become outstanding cardiologists. The CCU experience can be intense, but allows for a lot of flexibility by eliminating call from the remainder of the fellowship. Faculty are constantly seeking ways to improve the fellowship based on feedback and treat us as peers. 

How is your life in the Triangle area outside of work? 
After finishing my internal medicine training in Durham, it was a real challenge to consider moving. Quality of life as a medical trainee in the Triangle is unparalleled for a number of reasons. The cost of living is quite low, which provides disposable income. There is an excellent and constantly expanding culinary scene. My wife and I enjoy biking on the various greenways in the Triangle and taking weekend trips with our Labrador retriever to explore the Blue Ridge parkway and various breweries around Asheville. 


Black-Maier, E, Pokorney, SD, Barnett, AS, Zeitler, EP, Sun, AY, Jackson, KP, Bahnson, TD, Daubert, JP, and Piccini, JP. "Risk of atrioesophageal fistula formation with contact force-sensing catheters." Heart Rhythm 14, no. 9 (September 2017): 1328-1333.

Full Text

Black-Maier, E, Kim, S, Steinberg, BA, Fonarow, GC, Freeman, JV, Kowey, PR, Ansell, J, Gersh, BJ, Mahaffey, KW, Naccarelli, G, Hylek, EM, Go, AS, Peterson, ED, Piccini, JP, and Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators, . "Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation." Clinical Cardiology 40, no. 9 (September 2017): 746-751.

Full Text

Black-Maier, EW, Pokorney, SD, Barnett, AS, Liu, P, Shrader, P, Ng, J, Goldberger, JJ, Zareba, W, Daubert, JP, Grant, AO, and Piccini, JP. "Ranolazine reduces atrial fibrillatory wave frequency." Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 19, no. 7 (July 2017): 1096-1100.

Full Text

Black-Maier, E, and Piccini, JP. "Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs?." Heart (British Cardiac Society) 103, no. 11 (June 2017): 807-808.

Full Text

Black-Maier, E, Steinberg, BA, and Piccini, JP. "Bucindolol hydrochloride in atrial fibrillation and concomitant heart failure." Expert review of cardiovascular therapy 13, no. 6 (June 2015): 627-636. (Review)

Full Text